Physicians discuss how to tackle sexual harassment in academic medicine in commentaries appearing in the New England Journal of Medicine.
Eleven European countries call for free access to publicly funded science, the Economist reports.
In Science this week: algorithm to examine circadian expression of genes, and more.
ScienceInsider reports that universities may be worse than drug companies at reporting clinical trial results.
An op-ed at the New York Times points out that precision medicine's failures should also be discussed.
In Nature this week: saturation genome editing gives insight into BRCA1 variant functions, system to identify CRISPR off-target effects, and more.
Researchers have assembled the genome of the orange clownfish.
Brigham Young University team examines the genes of a 7'6" former NBA player, Technology Review reports.
Fortune discusses consumer genetic testing companies' privacy policies.
In Genome Research this week: queen bee chromatin profiles, quantitative trait loci and allele-specific expression in wild house mice, and more.
This year's winners of the Lasker Awards have studied histones, RNA biology, and more.
A federal appeals court in the US has upheld a judgment that gave the Broad Institute key CRISPR patents.
Population geneticist Luigi Luca Cavalli-Sforza has died, The Scientist reports.
In PNAS this week: influence of DNA architecture on genome editing, within-host HIV evolution, and more.
The New York Times reports that José Baselga, chief medical officer at Memorial Sloan Kettering Cancer Center, didn't always disclose industry ties.
In an editorial, the Washington Post calls on Congress to develop privacy standards to govern genetic testing companies.
Technology Review reports on cloud-based quantum computing services.
In PLOS this week: high-altitude adaptations among Tibetans, omic characterization of canine malignant melanoma, and more.
An FDA official says a policy limiting the hiring of foreign researchers is affecting the agency's ability to draw new employees, Stat News reports.
Hospitals and philanthropies in the US are forming their own drug company called Civica Rx.
23andMe has stopped allowing third-party apps access to anonymized genomic data, according to Wired.
In Science this week: common metastatic driver genes, inhibitors of CRISPR, and more.
A Senate committee voted unanimously yesterday to approve Kelvin Droegemeier as science advisor, Nature News reports.
CNBC reports that genetic testing company 23andMe is looking into offering a premium sequencing-based service.
Researchers from Synlogic are testing a synthetic biology-based treatment for phenylketonuria, according to the New York Times.
Gene editing is expected to give rise to new job opportunities, according to BBC Capital.
A new analysis finds that better grant-writing skills may help early-career researchers stay funded and stay in academia.
At Nature, a graduate student describes how to explore careers outside academia and what PhD programs can do help that search.
A new analysis of research funding finds that after receiving their first award, female researchers are just about as likely to receive additional awards as male researchers.